Successful treatment of refractory cutaneous Crohn's disease with upadacitinib: A case report.
Cure8 flagged this item because the article title and available source metadata connect it to Crohn's disease, Upadacitinib, JAK inhibitor, and Medications. We do not yet have enough reliable article text to summarize the details.
This may be most useful for Adult patients and Clinicians following Crohn's disease, Upadacitinib, JAK inhibitor, and Medications.
What To Know
Cure8 does not have enough reliable source text to summarize this article yet. Based on the article title and source metadata, this appears to be a case report related to Crohn's disease, Upadacitinib, JAK inhibitor, and Medications. Use the original source link for the full details.
The original article from JAAD case reports has the full details, including any study limitations or source context.
